U.S. House panel to take up bill to spur generic drug development

U.S. Rep. Greg Walden asks questions of the witnesses during a House Energy and Commerce Committee hearing on the Patient Protection and Affordable Care Act on Capitol Hill in WashingtonWASHINGTON (Reuters) – A U.S. House of Representatives subcommittee will take up bipartisan legislation next week to spur generic drug development, the committee's chairman Representative Greg Walden said on Thursday. "Specifically the bill will require FDA (Food and Drug Administration) to prioritize, expedite and review generic applications of drug products that are currently in shortage, or where there are few manufacturers on the market," Walden said at a health subcommittee hearing. (Reporting by Susan Cornwell; Editing by Chizu Nomiyama)

Go to Source

Anthem considering role in Obamacare insurance in 2018

The office building of health insurer Anthem is seen in Los Angeles, CaliforniaIndividual insurance created by former U.S. president Barack Obama's health reform law, often called Obamacare, has been a difficult business for Anthem and other large insurers, which say the enrollment rules skew the pool of patients toward those who are sick. U.S. President Donald Trump has vowed to repeal and replace the program, and his fellow Republicans have begun the process. Insurers, which had been seeking changes from Democrats under Obama, are now talking to Republicans.

Go to Source

Senate Democrats boycott committee vote on Mnuchin, Price

File photo of Steven Mnuchin testifying on his nomination to be Treasury secretary in WashingtonWASHINGTON (Reuters) – U.S. Senate Democrats on Tuesday boycotted a planned committee vote on two of President Donald Trump's nominees, Steve Mnuchin to be Treasury Secretary and Tom Price to head the Health and Human Services department, making it impossible for the vote to go forward. Democrats said they were delaying the vote because they wanted more information on Price's stock trades in an Australian medical company and reports that Mnuchin's former bank, OneWest, used automated "robosignings" of foreclosures, which apparently contradicted statements he made to senators. …

Go to Source

1 144 145 146 147 148 157